Connectomic Targeted TMS Target for Refractory Anxiety

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

August 1, 2028

Study Completion Date

February 1, 2029

Conditions
Anxiety DisordersMental DisorderPsychiatric Disorder
Interventions
PROCEDURE

Transcranial magnetic stimulation

Transcranial magnetic stimulation (TMS) is a focal, non-invasive form of brain stimulation that has FDA clearance for depression. In this study, a form of TMS called accelerated intermittent theta burst stimulation will be administered under the supervision of a physician with TMS expertise.

PROCEDURE

Sham transcranial magnetic stimulation

The sham TMS coil mimics the scalp sensation of real TMS by delivering a small amount of electrical current with a pair of surface electrodes.

Trial Locations (1)

02115

Emma Jones, Boston

All Listed Sponsors
lead

Brigham and Women's Hospital

OTHER